Imatinib 100 mg Tablet Imatib

Trade Name: Imatib

Manufacturer: Cipla Ltd

Presentation: Tablet

Strength: 100mg

What is the purpose of Imatinib 100 mg?

Imatinib 100 mg prevents some cancer cells from growing. Imatinib is a drug that is used to treat some types of leukemia, bone marrow abnormalities, and skin cancer.

What is the purpose of imatinib?

Imatinib mesylate is licensed to treat Philadelphia chromosome-positive acute lymphoblastic leukemia in adults and children. It is used to treat recurrent (comeback) or refractory disease in adults (does not respond to treatment).

What are the imatinib side effects?

  • More widespread
  • Pain, cramping, burning, or soreness in the abdomen or stomach.
  • wound bleeding following surgery
  • issues with bleeding
  • Face, hands, lower legs, or feet bloating or edoema
  • Urine with blood.
  • bloodshot eye
  • nose bleeding
  • The lips and fingernails are blue.

to know more click here

Is it possible to take Imatinib 100 mg at night?

The dose can be taken completely at once or split into two smaller doses (once in the morning and once in the evening). However, the daily intake is normally limited to 600 mg.

When do I start taking Imatinib 100 mg?

Imatinib is a drug that is used to treat some types of leukemia (cancer that starts in the white blood cells) as well as other malignancies and blood cell abnormalities.

Is Imatinib 100 mg safe to take for a long time?

Although the ideal therapy length is unknown, imatinib should often be continued for 6–9 months, beyond which tumor shrinkage is usually limited.

Is Imatinib 100 mg capable of causing anemia?

Introduction. With imatinib therapy for newly diagnosed chronic myeloid leukemia (CML) in the chronic phase, the incidence of grade 3–4 anemia was reported to be 3%. (CP). However, there are limited data on the causes of anemia and how it develops following long-term treatment.

What happens if I don’t take Imatinib 100 mg anymore?

After discontinuing imatinib for CML, 61 percent of patients eliminated undetectable minimal residual disease after a median of 2.5 months, with no recurrences after 22 months.

Imatinib weakens the immune system.

The medication accomplishes this by encouraging the bone marrow to produce more neutrophils and macrophages, immune cells critical for bacterial infection resistance. “This was unexpected because there have been indications that imatinib can weaken the immune system in some people,” Kalman explains.

We are a global wholesaler and exporter from India and operate in more than 5 countries like UAE, USA, Italy, Germany, Brazil, etc.  If you are looking for another product or brand click on our products.